Skip to content

Stryker SYK Price / earnings

Price / earnings at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
28×+9.7×
Boston Scientific logo
Boston ScientificBSX
26.2×-47.5×
Intuitive Surgical logo
Intuitive SurgicalISRG
55×-16.7×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
23.2×-1.4×
Medtronic logo
MedtronicMDT
21.7×-1.5×
STERIS logo
STERISSTE
27.7×-8.5×

Other financials

Income statement

See full
Revenue$6.0B+2.6%
Gross profit$3.8B+1.8%
Operating income$936.0M+11.8%
Net income$745.0M+13.9%
EPS (diluted)$1.93+14.2%

Balance sheet

See full
Cash & equivalents$2.9B+24.1%
Total debt$14.4B-15.1%
Total assets$46.3B+0.6%

Cash flow

See full
Operating cash flow$581.0M+132%
CapEx$166.0M+35.0%
Free cash flow$415.0M+227%

Valuation

See full
Market cap$115.45B-11.4%
Enterprise value$126.95B-12.4%
P/S4.6×-1.0×

Profitability

See full
Gross margin63.8%-0.1pp
Operating margin19.7%+4.4pp
Net margin13.2%+0.9pp

Returns & leverage

See full
Return on equity32.8%
Debt / equity0.8×
Current ratio2.1×+0.5×

Where this comes from

Calculated from Stryker’s reported figures.

Based on the most recent quarter.

The official record: Stryker’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stryker's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stryker's price / earnings?
Stryker (SYK) reported price / earnings of 37.7× in Q1 2026.
How has Stryker's price / earnings changed year-over-year?
Stryker's price / earnings decreased by 24.1% year-over-year, from 49.7× to 37.7×.
What is the long-term trend for Stryker's price / earnings?
Over 4 years (2021 to 2025), Stryker's price / earnings has grown at a -3.1% compound annual growth rate (CAGR), from 215.3× to 189.7×.
What does price / earnings mean?
How many dollars investors pay for each dollar of the company's annual profit.
How do you interpret price / earnings?
Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
How does price / earnings compare across companies?
Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.